AL-CONFEDERATE-MOTORS
Confederate Motorcycles, creator of the world’s most exotic road-going machines, has announced that its most advanced motorcycle yet, the P51 Combat Fighter , has been included in the production of Transformers: The Last Knight .
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170622005998/en/
The global luxury brand is excited to confirm that the Decepticon, Mohawk, will appear as a Fighter in its disguised vehicle form.
H. Matthew Chambers, CEO of Confederate Motorcycles, said: “The Fighter is pure yang power born to raise hell, so his transformation into the knife wielding, mayhem-causing, motorcycle punk is logical and interesting.”
Of the 61 Combat Collection special editions, each hand built by Confederate’s highly-skilled master craftsmen at its Birmingham headquarters, only two remain available for reservation.
Transformers: The Last Knight is now showing in theaters worldwide.
Confederate Motors, Inc. (CFED) is a rebel think tank 100% focused on creating the best and finest motorcycles with no compromise. Each motorcycle is handcrafted to be an heirloom work of art that looks and rides like rebellion itself. The enterprise is traded on the OTC under the symbol, CFED.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170622005998/en/
Contact:
Confederate Motors, Inc.
Jordan Cornille, 205-324-9888
info@confederate.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BUREAU-VERITAS25.4.2024 09:21:31 CEST | Press release
Bureau Veritas: Strong Start to the Year; 2024 Outlook Confirmed
TXONE-NETWORKS25.4.2024 09:05:30 CEST | Press release
New CPS Protection Platform: TXOne Networks Presents SageOne in Hannover
INFOBIP25.4.2024 09:01:30 CEST | Press release
Infobip becomes an Oracle Independent Software Vendor partner
LENOVO25.4.2024 05:01:26 CEST | Press release
Global CIOs geared up to scale AI but organizations aren’t as ready
MUNDIPHARMA24.4.2024 22:02:28 CEST | Press release
Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom